In this report, Datamonitor has estimated that there were a total of 2.3 million cases of Parkinson’s disease in 2011 in the seven major markets, with nearly a third of these being in the US. Incidence rates are expected to remain constant, while total prevalence rates will increase as a result of the aging population in the seven major markets.
Features and benefits
No. of Pages: 35
Price: Single User License: US$ 5700 Corporate User License: US$14250
Few points from Table of Contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Parkinson’s disease epidemiology
Parkinson’s disease in the seven major markets
Datamonitor’s forecast of Parkinson’s disease epidemiology
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Disease definition
GLOBAL VARIATION AND HISTORICAL TRENDS
Population structure-influenced Parkinson's disease prevalence rates across the world
Asia: highest prevalence in rural China
Americas: wide prevalence rates range in South America
Europe: sampling methods influenced prevalence rates
Prevalence rates differences: attributed to environmental differences
Historical trend: no changes in Parkinson's disease prevalence in the last 4 decades
Prevalence: increases sharply with age
Incidence: disease burden rising due to population increases and aging
Survival: dependent on co-morbidities
Mortality: improved treatment has lowered Parkinson's disease-related mortality
DRIVERS OF PARKINSON’S DISEASE EPIDEMIOLOGY
Risk factors that affect Parkinson’s disease epidemiology
Genetics and demographics
Age: strongest risk factor
Genetic predisposition: strong in patients under 50
Gender: more prevalent in males
Lifestyle factors
Lifestyle factors: role of smoking and diet
Other factors
Agricultural chemicals: strongest environmental risk factors
Features and benefits
- Gain insight into market potential, including a robust 10-year epidemiology forecast of prevalent Parkinson's disease cases.
- Understand the key epidemiologic risk factors associated with Parkinson's disease.
- What are the most robust epidemiologic studies for Parkinson's disease prevalence data?
- How will the patient population change through to 2021 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in prevalent Parkinson's disease cases?
Parkinson’s Disease Market
Published: April 2012No. of Pages: 35
Price: Single User License: US$ 5700 Corporate User License: US$14250
Few points from Table of Contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Parkinson’s disease epidemiology
Parkinson’s disease in the seven major markets
Datamonitor’s forecast of Parkinson’s disease epidemiology
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Disease definition
GLOBAL VARIATION AND HISTORICAL TRENDS
Population structure-influenced Parkinson's disease prevalence rates across the world
Asia: highest prevalence in rural China
Americas: wide prevalence rates range in South America
Europe: sampling methods influenced prevalence rates
Prevalence rates differences: attributed to environmental differences
Historical trend: no changes in Parkinson's disease prevalence in the last 4 decades
Prevalence: increases sharply with age
Incidence: disease burden rising due to population increases and aging
Survival: dependent on co-morbidities
Mortality: improved treatment has lowered Parkinson's disease-related mortality
DRIVERS OF PARKINSON’S DISEASE EPIDEMIOLOGY
Risk factors that affect Parkinson’s disease epidemiology
Genetics and demographics
Age: strongest risk factor
Genetic predisposition: strong in patients under 50
Gender: more prevalent in males
Lifestyle factors
Lifestyle factors: role of smoking and diet
Other factors
Agricultural chemicals: strongest environmental risk factors
